PUBLISHER: The Business Research Company | PRODUCT CODE: 1713623
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713623
Predictive Biomarkers Global Market Report 2025
Predictive biomarkers are biological indicators that help forecast an individual's likelihood of developing a disease or their response to a specific treatment. These markers, which can be genetic, proteomic, or molecular, provide valuable insights into disease susceptibility or treatment efficacy. They enable personalized treatment approaches, enhancing the effectiveness of interventions and potentially reducing adverse effects by identifying patients who are most likely to benefit from specific therapies.
The main indication types for predictive biomarkers include cancer, metabolic diseases, cardiovascular disorders, immunological disorders, and others. Predictive biomarkers for cancer, for example, can reveal a person's risk of developing cancer or predict their response to certain treatments. These biomarkers may include genetic mutations, protein levels, or other biological factors indicative of cancer presence or progression. Applications of predictive biomarkers encompass screening, analysis, diagnosis, prediction, and monitoring. End users of these biomarkers include diagnostic centers, contract research organizations, academic research institutes, pharmaceutical and biotech companies, and other relevant entities.
The predictive biomarkers market research report is one of a series of new reports from the business research company that provides predictive biomarkers market statistics, including predictive biomarkers industry global market size, regional shares, competitors with an predictive biomarkers market share, detailed predictive biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the predictive biomarkers industry. This predictive biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The predictive biomarkers market size has grown steadily in recent years. It will grow from $20.05 billion in 2024 to $20.96 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to increasing research and development investments, expansion of healthcare infrastructure, collaborations between academic institutions and industry, growing incidence of cancer and genetic disorders, and increased use of biomarkers in drug development.
The predictive biomarkers market size is expected to see steady growth in the next few years. It will grow to $24.67 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to increasing adoption of precision medicine, growing focus on preventive healthcare, rising healthcare expenditure, increased investment in biomarker-based diagnostics, expansion of biobanks and tissue repositories, and a rise in global health awareness. Major trends in the forecast period include integration of artificial intelligence in biomarker analysis, development of non-invasive biomarker testing, advancements in biomarker-based digital health tools, advancement in single-cell sequencing technologies, development of real-time biosensing and monitoring systems, and advancement in bioinformatics tools for data integration.
The increasing incidence of cancer is expected to drive the growth of the predictive biomarkers market. Cancer is characterized by uncontrolled cell growth that can invade and spread to other parts of the body. This rise in cancer cases is largely due to aging populations, lifestyle changes, and greater exposure to risk factors such as tobacco use, poor diets, and environmental pollutants. Predictive biomarkers help identify patients who are likely to benefit from specific treatments, enabling more personalized and effective therapies. For example, a report by the International Agency for Research on Cancer (IARC), a France-based agency of the World Health Organization (WHO) specializing in cancer research, indicated in April 2024 that there were nearly 20 million new cancer cases and about 10 million cancer-related deaths in 2022. Projections suggest that the number of new cancer cases will increase to 35 million annually by 2050, representing a 77% rise from 2022 levels. Consequently, the growing number of cancer cases is expected to boost the predictive biomarkers market.
Major companies in the predictive biomarkers market are increasingly leveraging technological advancements, such as AI-driven biomarker discovery, to accelerate biomarker development. This approach helps them gain a competitive edge by delivering more personalized and effective therapies more quickly. AI-driven biomarker discovery facilitates the analysis of large, complex datasets, uncovering predictive biomarkers that traditional methods might miss. For example, in July 2024, Scipher Medicine, Inc., a US-based precision immunology company, introduced PRoBeNet (Predictive Response Biomarkers using Network Medicine). This platform aims to speed up the development of predictive response biomarkers for complex diseases by using AI and network biology. PRoBeNet identifies biomarkers related to therapy response by integrating therapy-targeted proteins with disease-specific molecular signatures. It has been validated for autoimmune conditions such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease, and is applicable to other complex diseases and drug development stages.
In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology research company, acquired The Binding Site Group for £2.3 billion. This acquisition aims to strengthen Thermo Fisher's specialty diagnostics segment by incorporating The Binding Site's advanced diagnostic technologies, thereby enhancing oncology testing and patient care for multiple myeloma. The Binding Site Group, a UK-based provider of diagnostic solutions, offers various predictive biomarkers, especially in the fields of hematology and immunology.
Major companies operating in the predictive biomarkers market are Johnson & Johnson Services Inc, F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthcare GmbH, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Bio-Rad Laboratories Inc, QIAGEN GmbH, Almac Group Limited, ArcherDX Inc, Luminex Corporation, Guardant Health Inc, Meso Scale Diagnostics LLC, Myriad Genetics Inc, NanoString Technologies Inc, Fujirebio Inc, Asuragen Inc, Biognosys AG, Epigenomics AG, OncoCyte Corporation, Biomarker Technologies Inc
North America was the largest region in the predictive biomarkers market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the predictive biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The predictive biomarkers market consists of revenues earned by entities by providing services such as biomarker discovery, validation, and testing, as well as genetic screening, data analysis, and personalized medicine solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The predictive biomarkers market also includes sales of genetic testing kits, molecular diagnostic assays, genomic sequencing tools, and bioinformatics software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Predictive Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on predictive biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for predictive biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The predictive biomarkers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Indication: Cancer; Metabolic Disease; Cardiovascular Disorder; Immunological Disorder; Other Indications
- 2) By Application: Screening; Analysis; Diagnosis; Prediction; Monitoring
- 3) By End User: Diagnostic Centers; Contract Research Organizations; Academic Research Institutes; Pharms And Biotech Companies; Other End Users
- Subsegments:
- 1) By Cancer: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Ovarian Cancer; Leukemia And Lymphoma; Melanoma; Pancreatic Cancer; Kidney Cancer; Head And Neck Cancer
- 2) By Metabolic Disease: Type 1 and Type 2 Diabetes; Obesity; Metabolic Syndrome; Non-Alcoholic Fatty Liver Disease (NAFLD); Dyslipidemia; Insulin Resistance
- 3) By Cardiovascular Disorder: Atherosclerosis; Coronary Artery Disease; Heart Failure; Myocardial Infarction (Heart Attack); Arrhythmia; Hypertension; Stroke; Peripheral Arterial Disease
- 4) By Immunological Disorder: Autoimmune Diseases; Inflammatory Bowel Disease (IBD); Multiple Sclerosis; Psoriasis; Allergic Diseases; Asthma; Chronic Obstructive Pulmonary Disease (COPD); Immunodeficiency Disorders
- 5) By Other Indications: Neurological Disorders; Infectious Diseases; Renal Diseases; Osteoarthritis; Genetic Disorders; Respiratory Disorders
- Companies Mentioned: Johnson & Johnson Services Inc; F Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Predictive Biomarkers Market Characteristics
3. Predictive Biomarkers Market Trends And Strategies
4. Predictive Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Predictive Biomarkers Growth Analysis And Strategic Analysis Framework
- 5.1. Global Predictive Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Predictive Biomarkers Market Growth Rate Analysis
- 5.4. Global Predictive Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Predictive Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Predictive Biomarkers Total Addressable Market (TAM)
6. Predictive Biomarkers Market Segmentation
- 6.1. Global Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer
- Metabolic Disease
- Cardiovascular Disorder
- Immunological Disorder
- Other Indications
- 6.2. Global Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Screening
- Analysis
- Diagnosis
- Prediction
- Monitoring
- 6.3. Global Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic Centers
- Contract Research Organizations
- Academic Research Institutes
- Pharms And Biotech Companies
- Other End Users
- 6.4. Global Predictive Biomarkers Market, Sub-Segmentation Of Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Ovarian Cancer
- Leukemia And Lymphoma
- Melanoma
- Pancreatic Cancer
- Kidney Cancer
- Head And Neck Cancer
- 6.5. Global Predictive Biomarkers Market, Sub-Segmentation Of Metabolic Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Type 1 and Type 2 Diabetes
- Obesity
- Metabolic Syndrome
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- Dyslipidemia
- Insulin Resistance
- 6.6. Global Predictive Biomarkers Market, Sub-Segmentation Of Cardiovascular Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Atherosclerosis
- Coronary Artery Disease
- Heart Failure
- Myocardial Infarction (Heart Attack)
- Arrhythmia
- Hypertension
- Stroke
- Peripheral Arterial Disease
- 6.7. Global Predictive Biomarkers Market, Sub-Segmentation Of Immunological Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Autoimmune Diseases
- Inflammatory Bowel Disease (IBD)
- Multiple Sclerosis
- Psoriasis
- Allergic Diseases
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Immunodeficiency Disorders
- 6.8. Global Predictive Biomarkers Market, Sub-Segmentation Of Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neurological Disorders
- Infectious Diseases
- Renal Diseases
- Osteoarthritis
- Genetic Disorders
- Respiratory Disorders
7. Predictive Biomarkers Market Regional And Country Analysis
- 7.1. Global Predictive Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Predictive Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Predictive Biomarkers Market
- 8.1. Asia-Pacific Predictive Biomarkers Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Predictive Biomarkers Market
- 9.1. China Predictive Biomarkers Market Overview
- 9.2. China Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Predictive Biomarkers Market
- 10.1. India Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Predictive Biomarkers Market
- 11.1. Japan Predictive Biomarkers Market Overview
- 11.2. Japan Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Predictive Biomarkers Market
- 12.1. Australia Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Predictive Biomarkers Market
- 13.1. Indonesia Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Predictive Biomarkers Market
- 14.1. South Korea Predictive Biomarkers Market Overview
- 14.2. South Korea Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Predictive Biomarkers Market
- 15.1. Western Europe Predictive Biomarkers Market Overview
- 15.2. Western Europe Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Predictive Biomarkers Market
- 16.1. UK Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Predictive Biomarkers Market
- 17.1. Germany Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Predictive Biomarkers Market
- 18.1. France Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Predictive Biomarkers Market
- 19.1. Italy Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Predictive Biomarkers Market
- 20.1. Spain Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Predictive Biomarkers Market
- 21.1. Eastern Europe Predictive Biomarkers Market Overview
- 21.2. Eastern Europe Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Predictive Biomarkers Market
- 22.1. Russia Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Predictive Biomarkers Market
- 23.1. North America Predictive Biomarkers Market Overview
- 23.2. North America Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Predictive Biomarkers Market
- 24.1. USA Predictive Biomarkers Market Overview
- 24.2. USA Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Predictive Biomarkers Market
- 25.1. Canada Predictive Biomarkers Market Overview
- 25.2. Canada Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Predictive Biomarkers Market
- 26.1. South America Predictive Biomarkers Market Overview
- 26.2. South America Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Predictive Biomarkers Market
- 27.1. Brazil Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Predictive Biomarkers Market
- 28.1. Middle East Predictive Biomarkers Market Overview
- 28.2. Middle East Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Predictive Biomarkers Market
- 29.1. Africa Predictive Biomarkers Market Overview
- 29.2. Africa Predictive Biomarkers Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Predictive Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Predictive Biomarkers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Predictive Biomarkers Market Competitive Landscape And Company Profiles
- 30.1. Predictive Biomarkers Market Competitive Landscape
- 30.2. Predictive Biomarkers Market Company Profiles
- 30.2.1. Johnson & Johnson Services Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Predictive Biomarkers Market Other Major And Innovative Companies
- 31.1. Merck KGaA
- 31.2. Siemens Healthcare GmbH
- 31.3. Agilent Technologies Inc
- 31.4. PerkinElmer Inc
- 31.5. Illumina Inc
- 31.6. Bio-Rad Laboratories Inc
- 31.7. QIAGEN GmbH
- 31.8. Almac Group Limited
- 31.9. ArcherDX Inc
- 31.10. Luminex Corporation
- 31.11. Guardant Health Inc
- 31.12. Meso Scale Diagnostics LLC
- 31.13. Myriad Genetics Inc
- 31.14. NanoString Technologies Inc
- 31.15. Fujirebio Inc
32. Global Predictive Biomarkers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Predictive Biomarkers Market
34. Recent Developments In The Predictive Biomarkers Market
35. Predictive Biomarkers Market High Potential Countries, Segments and Strategies
- 35.1 Predictive Biomarkers Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Predictive Biomarkers Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Predictive Biomarkers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
- 250423_r33525_Predictive_Biomarkers_GMR_2025
